Efficacy of ACE Retino and Cataclear in Treating Adult Corneal Opacity

Here’s What It’s About:

This case report follows a 27-year-old patient with severe corneal opacity treated over 90 days using ACE Retino (sublingual and topical peptides) and Cataclear (bioactive eye drops).

Key observations include:

• 92% improvement in corneal clarity
• Significant visual acuity gains
• Reduced stromal edema
• And marked improvements in inflammatory and oxidative biomarkers – all without surgical intervention.

💡 Why This Matters:

Corneal opacity affects millions globally and often requires surgery with associated risks. This preliminary case suggests peptide-based therapies targeting inflammation, oxidative stress, and fibrosis may offer a promising non-invasive alternative – though larger controlled trials are needed.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/